The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 355:1863-1872 November 2, 2006 Number 18
NextNext

Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia
Jaroslaw Regula, M.D., Maciej Rupinski, M.D., Ewa Kraszewska, M.Sc., Marcin Polkowski, M.D., Jacek Pachlewski, M.D., Janina Orlowska, M.D., Marek P. Nowacki, M.D., and Eugeniusz Butruk, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
ABSTRACT

Background Recommendations for colorectal-cancer screening are based solely on age and family history of cancer, not sex.

Methods We performed a cross-sectional analysis of the data from a large colonoscopy-based screening program that included 50,148 participants who were 40 to 66 years of age. People 40 to 49 years of age were eligible only if they had a family history of cancer of any type. Of the 43,042 participants 50 to 66 years of age, 13.3% reported a family history of colorectal cancer, as did 66.3% of the 7106 participants who were 40 to 49 years of age. We defined advanced neoplasia as cancer or adenoma that was at least 10 mm in diameter, had high-grade dysplasia, or had villous or tubulovillous histologic characteristics, or any combination thereof. We used multivariate logistic regression to identify associations between participants' characteristics and advanced neoplasia in a primary (or derivation) data set, and we confirmed the associations in a secondary (or validation) data set.

Results Advanced neoplasia was detected in 2553 (5.9%) participants 50 to 66 years of age and in 243 (3.4%) participants 40 to 49 years of age. The rate of complications during colonoscopy was 0.1%, and no participants died. In the validation set, a logistic-regression model showed that male sex was independently associated with advanced neoplasia (adjusted odds ratio, 1.73; 95% confidence interval, 1.52 to 1.98; P<0.001). In each age group (40 to 49 years, 50 to 54 years, 55 to 59 years, and 60 to 66 years), the number of persons who would have to undergo colorectal-cancer screening in order to detect one advanced neoplasia was significantly lower in men than in women (23 vs. 36, 17 vs. 28, 12 vs. 22, and 10 vs. 18, respectively).

Conclusions We detected advanced neoplasia at a significantly higher rate in men than in women, which may warrant refinement of the screening recommendations for colorectal cancer.


Source Information

From the Department of Gastroenterology, Medical Center for Postgraduate Education, and the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (J.R., M.R., M.P., J.P., J.O., E.B.); and the Departments of Biostatistics (E.K.) and Colorectal Cancer (M.P.N.), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology — all in Warsaw, Poland.

Address reprint requests to Dr. Regula at the Department of Gastroenterology, Maria Sklodowska-Curie Memorial Cancer Center, Roentgen St. 5, 02-784 Warsaw, Poland, or at jregula{at}coi.waw.pl.

Full Text of this Article


Related Letters:

Colonoscopy Screening for Detection of Advanced Neoplasia
Latreille M. W., Anderson J. C., Maisonneuve P., Lowenfels A. B., Picca S. M., Regula J., Polkowski M., Butruk E.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:632-634, Feb 8, 2007. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.